A Neurologist Answers Questions Patients Might Have about the New Alzheimer’s Drug Lecanemab
No drug with consistent statistical evidence from clinical trials had ever been found to slow the course of Alzheimer’s disease before the Food and Drug Administration gave its nod this month to lecanemab, which clears the brain of the toxic amyloid protein that has been a primary target for drug developers. Lecanemab, marketed as Leqembi
Adorable Voles, Life as We Don’t Know It and Better Cement
Love in the brain, how dreams predict disease and better words for climate change in this month’s issue of Scientific American Credit: Scientific American, February 2023Every once in a while we publish a story that makes the editorial team at Scientific American melt. When we were reviewing illustrations for “The Neurobiology of Love” about pair-bonding
What an Endless Conversation with Werner Herzog Can Teach Us about AI
An AI-generated conversation between Werner Herzog and Slavoj Žižek is definitely entertaining, but it also illustrates the crisis of misinformation beginning to befall usFilmmaker Werner Herzog (left) and philosopher Slavoj Žižek (right) are not in the same room in this composite image. But on the website Infinite Conversation, clones of their voices are deep in
Free Will Is Only an Illusion if You Are, Too
Credit: francescoch/Getty ImagesImagine you are shopping online for a new pair of headphones. There is an array of colors, brands and features to look at. You feel that you can pick any model that you like and are in complete control of your decision. When you finally click the “add to shopping cart” button, you
Exxon’s Own Models Predicted Global Warming–It Ignored Them
It’s been seven years since journalists first revealed Exxon Mobil Corp.’s decadeslong efforts to undermine the scientific certainty around climate change, despite knowing how serious a problem it was. Now, a new analysis demonstrates exactly how much the company knew — and how its public disinformation campaigns sabotaged the warnings of its own scientists. Exxon
Popular
